Literature DB >> 30478638

[Non-drug treatment of rheumatoid arthritis : An analysis of claims data and a survey of insured persons (Project PROCLAIR)].

H Jacobs1, J Callhoff2, F Hoffmann3, A Zink2,4, K Albrecht2.   

Abstract

BACKGROUND: Only small amounts of data are available on the prescription frequency of physical therapies (PT) for patients with rheumatoid arthritis (RA).
OBJECTIVE: The aim of the study was to evaluate prescription frequencies of PT considering functional status and sociodemographic factors.
MATERIAL AND METHODS: A total of 98,963 adults diagnosed with RA in 2013 were identified in claims data from the BARMER health insurance. A questionnaire was sent to a representative sample of 6193 people requesting information on the disease status. Of these 2535 persons were included who agreed to the linking of the questionnaire and claims data and who confirmed a diagnosis of RA. From the routine claims data the prescription of PT and occupational therapy as well as the medical discipline of the prescribing physician were analyzed. Multivariable logistic regression was conducted to determine which variables (age, sex, M05/M06 diagnosis, residential area, income, functional status and rheumatological care) were associated with the use of PT.
RESULTS: In 2015 a total of 47% of the study population received PT (35% physiotherapy, 15% thermotherapy, 15% manual therapy, 2% electrotherapy and 6% massage) and 3% occupational therapy. Of the PT prescriptions 37% were issued by general practitioners, 27% by orthopedists and 18% by rheumatologists. Women and persons living in the eastern states of Germany and patients with high functional impairment were prescribed PT more often. Income, educational status, seropositivity and rheumatological care did not have any influence on the frequency of prescription of PT.
CONCLUSION: There are deficits in the outpatient prescription of PT but without indications of an undersupply of population groups due to low socioeconomic status. In contrast to the prescription of disease-modifying antirheumatic drug (DMARD) treatment, PT is predominantly prescribed by general practitioners.

Entities:  

Keywords:  Health services research; Occupational therapy; Physical therapy; Physiotherapy; Rheumatoid arthritis

Mesh:

Substances:

Year:  2019        PMID: 30478638     DOI: 10.1007/s00393-018-0567-6

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  4 in total

Review 1.  [Reality of care for musculoskeletal diseases at the population level : Results of the PROCLAIR collaborative project. German version].

Authors:  J Callhoff; K Albrecht; F Hoffmann; D Poddubnyy; K-P Günther; A Zink
Journal:  Z Rheumatol       Date:  2019-10       Impact factor: 1.372

Review 2.  [Multimodal rheumatological complex treatment : A current inventory].

Authors:  Philipp Klemm; Ulf Müller-Ladner; Uwe Lange
Journal:  Z Rheumatol       Date:  2022-03-29       Impact factor: 1.372

Review 3.  [Celebrating 33 years of the DRFZ: Epidemiology and Health Services Research].

Authors:  Anja Strangfeld; Katinka Albrecht; Anne Regierer; Johanna Callhoff; Angela Zink; Kirsten Minden
Journal:  Z Rheumatol       Date:  2022-04-05       Impact factor: 1.530

4.  [Prescription frequency of physical therapy for inflammatory rheumatic diseases].

Authors:  Katinka Albrecht; Ursula Marschall; Angela Zink; Johanna Callhoff
Journal:  Z Rheumatol       Date:  2022-03-22       Impact factor: 1.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.